In 2010, the World Health Organization recommended that every suspected malaria case be confirmed by an approved parasitological test prior to treatment. Subsequently, the Uganda Ministry of Health (MoH) adopted these guidelines and switched policy from presumptive treatment of malaria to targeted treatment, hence the test, treat, and track policy.
This policy not only strengthens surveillance of confirmed malaria cases, but also affords the country much benefit including minimized wastage of drugs, avoiding selection of drug resistance, and reducing exposure of patients to adverse events associated with unnecessary anti-malarial drug treatments. Despite all the efforts taken to operationalize the policy, reports indicated that antimalarial therapy continues to be prescribed even following a negative malaria test result or even without conducting a test.
However, there was a dearth of information on the extent and specific reasons for non-adherence to the malaria test, treat, and track policy. With funding from the Global Fund through the National Malaria Control Division of the MoH, the Public Health Fellowship Program conducted a study to describe and document malaria testing practices in healthcare facilities, assess the levels of non-adherence to the policy by clinicians, determine factors associated with non-adherence to malaria test results, and assess capacity for malaria surveillance in Uganda.